Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients

Oncotarget

Volumn 7, Issue 12, 2016, Pages 14510-14521

  Lamanuzzi, Aurelia ^a   Saltarella, Ilaria ^a   Ferrucci, Arianna ^a   Ria, Roberto ^a   Ruggieri, Simona ^a   Racanelli, Vito ^a   Rao, Luigia ^a   Annese, Tiziana ^a   Nico, Beatrice ^a   Vacca, Angelo ^a   Ribatti, Domenico ^a,b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Endothelial cells; Erythropoietin; Monoclonal gammopathy of undetermined significance; Multiple myeloma

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; JANUS KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT5 PROTEIN; VASCULOTROPIN; EPO PROTEIN, HUMAN; TUMOR MARKER; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CELL PROLIFERATION; CELLS BY BODY ANATOMY; CHORIOALLANTOIC MEMBRANE ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PARACRINE SIGNALING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BONE MARROW; CELL MOTION; CHICKEN; CONDITIONED MEDIUM; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHARMACOLOGY; TUMOR CELL CULTURE; VASCULARIZATION;

ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; BONE MARROW; CELL MOVEMENT; CELL PROLIFERATION; CHICKENS; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ERYTHROPOIETIN; HUMANS; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, ERYTHROPOIETIN; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84971607216     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7587     Document Type: Article

References (36)

1. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico B, Gernone A, Battelli F, Tabilio A, Guidolin D, Petrucci MT, et al. Endothelial cells in the bone marrow of patients with multiple myeloma. Blood. 2003; 102:3340-3348.
2. Ribatti D. Angiogenic effects of erythropoietin. Int Rev Cell Mol Biol. 2012; 299:199-234.
3. Kertesz N, Wu J, Chen THP, Sucov HM, Wu H. The role of erythropoietin in regulating angiogenesis. Dev Biol. 2004; 276:101-110.
4. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci. 1990; 87:5978-5982.
5. Ashley RA, Dubuque SH, Dvorak B, Woodward SS, Williams SK, Kling PJ. Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells. Pediatr Res. 2002; 51:472-478.
6. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney International. 1995; 47:740-745.
7. Ribatti D, Presta M, Vacca A, Ria R, Giuliani R, Dell'Era P, Nico B, Roncali L, Dammacco F. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood. 1999; 93:2627-36.
8. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miyatake K, Nakano Y. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996; 239:494-500.
9. Vogel V. Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells. Am J Hypertens. 1997; 10:289-296.
10. Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci. 1994; 91:3974-3978.
11. Carlini RG, Dusso AS, Obialo CI, Alvarez UM, Rothstein M. Recombinant human erythropoietin (rHuEPO) increases endothelin-1release by endothelial cells. Kidney International. 1993; 43:1010-1014.
12. Ribatti D, Nico B, Vacca A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene. 2006; 25:4257-4266.
13. Perelman N. Placenta growth factor activates monocytes and correlates with sickle cell disease severity. Blood. 2003; 102:1506-1514.
14. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke. 2004; 35:1732-1737.
15. Nakano M, Satoh K, Fukumoto Y, Ito Y, Kagaya Y, Ishii N, Sugamura K, Shimokawa H. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res. 2007; 100:662-669.
16. Okazaki T, Ebihara S, Asada M, Yamanda S, Niu K, Arai H. Erythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesis. Neoplasia. 2008; 10:932-939.
17. Hardee ME, Cao Y, Fu P, Jiang X, Zhao Y, Rabbani ZN, Vujaskovic Z, Dewhirst MW, Arcasoy MO. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression. PLoS ONE. 2007; 2:e549.
18. Li H-G, Li J-S, Chen W-L, Wang L, Wu D-H, Lin Z-Y. Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma. Br J Oral Maxillofac Surg. 2009; 47:470-475.
19. Nico B, Annese T, Guidolin D, Finato N, Crivellato E, Ribatti D. Epo is involved in angiogenesis in human glioma. J Neuro-Oncol. 2010; 102:51-58.
20. Ribatti D, Marzullo A, Gentile A, Longo V, Nico B, Vacca A, Dammacco F. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma. Histopathol. 2007; 50:591-596.
21. Ribatti D, Poliani PL, Longo V, Mangieri D, Nico B, Vacca A. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma. Histopathol. 2007; 50:636-641.
22. Wang L. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma. WJG. 2011; 17:3933.
23. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 2003; 4:459-460.
24. Powles T, Shamash J, Liu W. Erythropoietin to treat anaemia in patients with head and neck cancer. Lancet. 2004; 363:82.
25. Lin Y-T, Chuang H-C, Chen C-H, Armas G, Chen H-K, Fang F-M, Huang C-C, Chien C-Y. Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma. BMC Cancer. 2012; 12:194.
26. Volgger B, Kurz K, Zoschg K, Theurl I, Ciresa-Konig A, Marth C, Weiss G. Importance of erythropoietin receptor expression in tumour tissue for the clinical course of breast cancer. Anticancer Res. 2010; 30:3721-3726.
27. Olujohungbe A, Handa S, Holmes J. Does erythropoietin accelerate malignant transformation in multiple myeloma? Postgrad Med J. 1997; 73:163-164.
28. Bunworasate U. Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia. Blood. 2001; 98:3492-3494.
29. Cao Y. Erythropoietin in cancer: a dilemma in risk therapy. Trends Endocrinol Metab. 2013; 24:190-199.
30. Arcasoy MO, Amin K, Karayal AF, Chou S-C, Raleigh JA, Varia MA, Haroon ZA. Functional significance of erythropoietin receptor expression in breast cancer. Lab Invest. 2002; 82:911-918.
31. Yasuda Y, Fujita Y, Masuda S, Musha T, Ueda K, Tanaka H, Fujita H, Matsuo T, Nagao M, Sasaki R, Nakamura Y. Erythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organs. Carcinogenesis. 2002; 23:1797-1805.
32. Tovari J, Gilly R, Raso E, Paku S, Bereczky B, Varga N, Vago A, Tímar J. Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models. Cancer Res. 2005; 65:7186-7193.
33. De Luisi A, Binetti L, Ria R, Ruggieri S, Berardi S, Catacchio I, Racanelli V, Pavone V, Rossini B, Vacca A, Ribatti D. Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma. Angiogenesis. 2013; 16:963-973.
34. Ria R, Todoerti K, Berardi S, Coluccia AML, De Luisi A, Mattioli M, Ronchetti D, Morabito F, Guarini A, Petrucci MT, Dammacco F, Ribatti D, Neri A, et al. Gene expression profiling of bone marrow endothelial cells in patients with multiple myeloma. Clin Cancer Res. 2009; 15:5369-5378.
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using Real-Time Quantitative PCR and the 2-ΔΔCT Method. Methods. 2001; 25:402-408.
36. Ribatti D, Nico B, Vacca A, Presta M. The gelatin sponge-chorioallantoic membrane assay. Nature Protocols. 2006; 1:85-91.